Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 181 - 210 of 320
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Mircera - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Mirena 20 mikrog-24 tuntia depotlääkevalmiste, kohtuun PL 2023-05-22
SPC	Resepti	Mirtagav 15 mg, 30 mg, 45 mg tabletti PIL 2010-05-05
SPC	Resepti	Mirtamerck 15, 30, 45 mg tabletti PIL 2005-05-11
SPC	Resepti	Mirtazapin Actavis 15 mg, 30 mg tabletti, kalvopäällysteinen PL 2023-06-20
SPC	Resepti	Mirtazapin Hexal 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen PL 2020-08-10
SPC	Resepti	Mirtazapin Krka 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen PL 2021-11-22
SPC	Resepti	Mirtazapin Orion 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen PL 2021-07-14
SPC	Resepti	Mirtazapin Orion 15, 30, 45 mg suussa hajoava tabletti PL 2021-06-28
SPC	Resepti	Mirtazapin ratiopharm 15 mg, 30 mg tabletti, kalvopäällysteinen PL 2021-08-06
SPC	Resepti	Mirtazapin ratiopharm 45 mg tabletti, kalvopäällysteinen PL 2023-06-20
SPC	Resepti	Mirtazapin Sandoz 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen PL 2024-03-12
SPC	Resepti	Mirtazapin Teva 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen PL 2023-05-03
SPC	Resepti	Mirtazapine Actavis 15, 30, 45 mg tabletti PIL 2004-01-20
SPC	Resepti	Mirtazapine STADA 15 mg, 30mg, 45mg PL 2010-11-22.doc
		European Medicines Agency's website: Mirvaso - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Misbadi 110 mg kapseli, kova PL 2023-07-05.docx
SPC	Resepti	Misbadi 150 mg kapseli, kova PL 2023-07-05.docx
SPC	Resepti	Misbadi 75 mg kapseli, kova PL 2023-07-05.docx
SPC	Resepti	Mitomycin Accord 20 mg injektio-infuusiokuiva-aine liuosta varten - virtsarakkoon 2022-08-12
SPC	Resepti	Mitomycin Medac 40 mg jauhe ja liuotin liuosta varten, virtsarakkoon PL 2024-01-16
SPC	Resepti	Mitomycin medac, 1 mg-ml, injektio-infuusiokuiva-aine, liuosta varten virtsarakkoon PL 2021-01-14
SPC	Resepti	Mitomycin Substipharm 20 mg, injektio/infuusiokuiva-aine, liuosta varten PL 2023-06-09
SPC	Resepti	Mitomycin Substipharm 20 mg, jauhe ja liuotin liuosta varten, virtsarakkoon PL 2023-06-09
SPC	Resepti	Mitoxantron Ebewe 2 mg-ml infuusiokonsentraatti, liuosta varten PL 2021-06-15
SPC	Resepti	Mivacron 2 mg-ml injektioneste, liuos PL 2020-10-01
		European Medicines Agency's website: Mixtard - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Mobic 15 mg tabletti PL 2023-06-19
SPC	Resepti	Mobic 7.5 mg tabletti PL 2023-06-19
SPC	Itsehoito	Mobilat emulsiovoide PL 2020-06-30
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >